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INTRODUCTION
The GATA zinc finger transcription factors play a crucial role
in the development and differentiation of a number of tissues.
These factors bind the basic consensus sequence A/TGATA/G
through a conserved Cys-X2-Cys-X17-Cys-X2-Cys zinc finger
protein motif. Three members of the family, GATA1, GATA2
and GATA3, are all expressed in the haematopoietic system
and a number of other (non-overlapping) tissues (Leonard et
al., 1993). Each appears to have a different function in the
haematopoietic system as the inactivation of each of the genes
has shown a different phenotype (Pevny et al., 1991; Simon et
al., 1992; Tsai et al., 1994; Weiss et al., 1994; Pandolfi et al.,
1995; Ting et al., 1996). Three additional members of the
GATA family, GATA4, GATA5 and GATA6, also show a
partially overlapping expression pattern in the heart and the
intestinal tract (Laverriere et al., 1994; Jiang and Evans, 1996).
GATA4 is expressed as early as 7 dpc (days postcoitum) in the
prospective cardiac splanchic mesoderm (Arceci et al., 1993;
Kelley et al., 1993; Heikinheimo et al., 1994) and continues to
be expressed in the endocardium and the myocardium of the
folding heart tube. It is finally expressed in the cardiac
myocytes throughout development and adult life. Inactivation
of the GATA4 gene leads to defects in heart tube formation and
ventral morphogenesis in vivo (Kuo et al., 1997; Molkentin et
al., 1997) and defective visceral endoderm formation by
embryonic stem (ES) cells in vitro (Soudais et al., 1995). The
cardiac expression of murine GATA5 is first detected in the
precardiac mesoderm. It subsequently appears in the atrial and
ventricular chambers and becomes restricted to the atrial
endocardium (Morrisey et al., 1997). The consequences of
inactivation of the murine GATA5 gene have not been fully
described but the mice are viable indicating that it may share
functions with GATA4 and GATA6 (Molkentin et al., 1997).
Murine GATA6 has been reported to be restricted to precardiac
mesoderm, the embryonic heart tube and the primitive gut. It
is also expressed in the developing respiratory and urogenital
tracts, arterial smooth muscle cells, the bronchi, the urogenital
tract and the bladder (Morrisey et al., 1996; Narita et al., 1996;
Suzuki et al., 1996). In Xenopus, the expression of GATA6 has
first been detected at the beginning of gastrulation in the
mesoderm and subsequently in the precardiac cells (Gove et
al., 1997). Overexpression of GATA6 in the cardiac cells at a
time when its expression normally declines (i.e. before the
appearance of terminally differentiated markers) results in
arrest of cardiomyogenic differentiation, indicating that the
GATA6 gene may act in Xenopus to maintain the precursor
status (Gove et al., 1997). Thus the available data indicates that
GATA6 may be important for heart development. In order to
address this question, we first investigated the expression
pattern of the murine GATA6 gene by homologous
recombination of a lacZ reporter gene into the GATA6 locus,
which also enables us to generate a null mutation. The results
show that the expression of the GATA6-driven lacZ gene in
heterozygote mice is first detected before implantation in the
blastocyst, followed by expression in the parietal endoderm
just after gastrulation and subsequently in lateral plate
mesoderm and the cells that will form the heart and the gut.
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The gene coding for the murine transcription factor
GATA6 was inactivated by insertion of a b -galactosidase
marker gene. The analysis of heterozygote GATA6/lacZ
mice shows two inductions of GATA6 expression early in
development. It is first expressed at the blastocyst stage in
part of the inner cell mass and in the trophectoderm. The
second wave of expression is in parietal endoderm
(Reichert’s membrane) and the mesoderm and endoderm
that form the heart and gut. Inactivation leads to a lethality
shortly after implantation (5.5 days postcoitum). Chimeric
experiments show this to be caused by an indirect effect on
the epiblast due to a defect in an extraembryonic tissue.
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However, GATA6-deficient embryos die before heart
formation, showing abnormalities at 5.5 dpc, due to an
extraembryonic defect. Thus of all the mammalian GATA
factors that have been studied to date (GATA1-GATA6),
GATA6 appears to be the one that is required earliest in
embryonic development.
MATERIALS AND METHODS
Construction of the targeting vectors
The mouse GATA6 cDNA was cloned by screening a mouse 11.5 dpc
cDNA library (CLONTECH) with the human GATA6 cDNA as probe.
One cosmid containing the mouse genomic locus was isolated from
an 129 library using the cDNA probe. For the targeting vector, a 9.5
kb KpnI fragment containing the first ATG was subcloned into psp72
containing the PyEn-HSV thymidine kinase (TK) gene. The lacZ-
PMC1NEO cassette (Nuez et al., 1995) was introduced as a NotI
fragment in the same frame of the GATA6 cDNA into the unique NotI
site, 79 nt downstream of the ATG (Fig. 1A). To target the second
allele, the same construct was used but instead of the lacZ-PMC1NEO
cassette the hygromycin-resistance gene under the PGK promoter was
inserted.
ES cells transfection, analysis and differentiation
E14 ES cells were transfected, as described (Hendriks et al., 1996),
with 20 m g KpnI linearized targeting vector (Fig. 1A). Selection (200
m g/ml G418 or 160 m g/ml hygromycin B and 02 mM FIAU) was
applied 24 hours after transfection and resistant clones were picked 8
to 10 days later. 560 individual clones were assayed for b -
galactosidase activity and the 41 b -gal positives were further analyzed
by Southern blotting using 5¢ external and lacZ probe (Fig. 1B). 18
were homologous recombinants and a normal karyotype was
confirmed for three of them. Double mutant ES cells were
differentiated in vitro along with the parental heterozygous mutant
clone according to standard protocols (Doetschman et al., 1985,
Rohwedel et al., 1994) using mainly the suspension culture method.
Gel mobility-shift assays
1-week-old embryoid bodies were homogenized mechanically to
obtain single-cell suspensions and whole-cell extracts were prepared
as has been previously described (Meijer et al., 1990). Gel mobility
shift experiments were performed as has been reported (Whyatt et al.,
1993) using 1.2 and 1.4 m g of protein from wild-type and mutant cells
extracts, respectively. For GATA binding, the high-affinity site of the
C31T oligo (Whyatt et al., 1993) was used and for control competition
the –200 oligo (deBoer et al., 1988) as well as the Sp1 oligo (Philipsen
et al., 1990) were used. The antibody for GATA4 was kindly provided
by David Wilson.
Generation of chimeric mice and embryos
Two independent targeted clones were injected into C57BL/6 host
blastocysts (Robertson, 1987) and males highly chimeric for coat
colour were mated to FVB and C57BL/6 females to generate mice
heterozygous for the mutation. Double mutants ES cells were injected
into C57BL/6 blastocysts, which were transferred to foster females.
Recipients were killed on day 8 or 9 of pregnancy to dissect out the
chimeric embryos. Wild-type ES cells were injected into blastocysts
derived from heterozygous intercrosses and the chimeric embryos
were dissected at 7.5 dpc.
Genotyping of the embryos
Embryos from heterozygous matings were dissected according to
standard methods (Hogan et al., 1994) and part or all of the embryo,
older or younger than 7.5 dpc, respectively, was used for PCR
analysis, as described (Marin et al., 1997), using three primers (Fig.
1A). A sense primer in the GATA6 gene 150 nt 5 ¢ to the NotI site (P1:
5¢ -AGCAAGCTGTTGTGGTCCAC-3¢ ), an antisense 81 nt 3¢ to NotI
(P2: 5 ¢ -TAACGCCAGGGTTTTCCCAG-3 ¢ ), resulting in a 231 and
375 bp fragment for the wild type and targeted allele, respectively
(Fig. 1D).
Whole-mount in situ analysis
b -galactosidase activity was determined in embryonic materials, as
described (Marin et al., 1997; Hogan et al., 1994), with fixation time
varying from 1 minute for cells, embryoid bodies, blastocysts and
blastocyst outgrowths to 3, 5, 12 and 30 minutes for 5.5, 7.5, 8.5 and
9.5 dpc embryos, respectively. After overnight staining at 37°C, the
embryos were postfixed in the same fixative overnight at 4°C. For
histological analysis, 5-7 m m sections were obtained from stained and
postfixed materials, subsequent to paraffin embedding according to
standard protocols but using isopropanol instead of xylene.
In vitro culture of blastocyst
Blastocysts were flushed out at day 3.5 of pregnancy in M2 medium
and cultured in ES medium without LIF, in 5% CO2 at 37°C, on
gelatinized multichambered glass slides. After 5-9 days in culture, the
slides were mounted in PBS for photography and subsequently the
cells were scraped off and collected with a mouth pipette for PCR
genotyping as described for young embryos.
FISH genotyping
At embryonic day 7.5, chimeric embryos were dissected out of their
Reichert’s membranes and both embryo and membrane were kept in
small volume of PBS on ice. When dissection was completed, the PBS
was spun out and the cells were exposed in hypotonic solution for 10
minutes prior to cytospin on glass slides (Haaf and Ward, 1994). The
preparations were fixed in 75% methanol/25% acetic acid for 5
minutes and further processed for FISH as has been described (Mulder
et al., 1995; Milot et al., 1996).
RESULTS
GATA6 inactivation by lacZ insertion
We first studied the pattern of expression of the GATA6 gene
prior to and during heart formation by placing a lacZ reporter
gene under the control of the endogenous murine GATA6 gene.
This insertion also inactivated the gene coding for GATA6
protein (Fig. 1). The lacZ-neomycin resistance cassette was
cloned in frame, 79 nucleotides downstream from the ATG
start codon of the GATA6 gene (NotI site), creating a cassette
with 6.5 and 3 kb of 5 ¢ and 3¢ flanking sequence homologous
to the GATA6 gene and a HSV-TK gene for counterselection
purposes (Hendriks et al., 1996). The plasmid was transfected
into E14 ES cells and 560 clones were isolated after selection
and counterselection (see Materials and Methods). It was
expected that homologously recombined clones would stain
positively for b -gal, since northern blot analysis showed that
undifferentiated ES cells expressed GATA6 RNA (data not
shown). Thus the 41 clones positive for b -gal staining were
selected for further analysis. Southern blot analysis with probes
external and internal to the transfected cassette (Fig. 1A,B,
probes A and B) showed that 18 clones had undergone
homologous recombination placing the lacZ gene under
GATA6 control. Homologous recombination results in two
restriction fragments after a ClaI digest with the external probe
A; the original 15 kb fragment and a novel 6.4 kb fragment
created by the presence of a novel ClaI site in the lacZ gene
(Fig. 1B, left panel). A lacZ probe (Fig. 1B, right panel) detects
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the same 6.4 kb restriction
fragment, while a non-
homologous recombinant (+/+
lane) shows the 4 kb fragment
internal to the vector between the
lacZ ClaI site and the plasmid ClaI
site (Fig. 1A, targeting construct
and mutant GATA6). Although all
18 clones contained b -gal-positive
cells, not all cells within a clone
were stained. This may be because
ES cell clones are a mixture of
differentiated and undifferentiated
cells or more interestingly that
undifferentiated ES cells express
GATA6 only part of the time or
express only one of the two
GATA6 alleles.
The GATA6+/- embryonic stem
cells were retransfected with a
second homologous recombination
vector. This vector was identical to
the first vector with the exception
that the neo selection marker was
replaced by a hygro selection gene
(Marin et al., 1997). Homologous
recombinants were identified as
described for the heterozygous
knockout above, resulting in 10
clones of homozygous GATA6- / -
embryonic stem cells out of 96
clones analyzed. We used three
different GATA6 antibodies
(Nakagawa et al., 1997; Perlman et
al., 1998 and Santa Cruz) to show
the absence of GATA6 protein in
GATA6- /- cells. However, none of
the antibodies was able to detect
specifically GATA6 protein on
western blots in wild-type cells.
We therefore assayed GATA6-
binding activity in vitro using a
high-affinity GATA-binding site,
C31T oligo (Whyatt et al., 1993)
and protein extracts from one week
in vitro differentiated ES cells
(Fig. 1C). As expected, only one
major shift was observed
since GATA6-binding activity
comigrates with that of GATA4
(Morrisey et al., 1996). In extracts
from wild-type cells, this shift
decreased significantly by the
addition of either 0.5 or 1 m l of
anti-GATA4 antibody and resulted
in a supershift (Arceci et al., 1993).
The GATA shift was reduced
significantly in the double mutant
cell extract and disappeared almost
completely by the addition of anti-
GATA4 antibody while producing
Fig. 1. Targeted disruption of the GATA6 gene. (A) Schematic representation of the targeting
strategy. Top line: Partial restriction map of the murine GATA6 locus in which the ATG is indicated
with the arrowhead. Middle line: Targeting vector containing the polyoma enhancer-herpes simplex
virus thymidine kinease (tk) gene and the neomycin resistance gene under the mouse
phosphoglycerate kinase (PGK) promoter following the E.coli b -galactosidase (lacZ) gene. Bottom
line: The mutant GATA6 locus resulting from the in frame insertion of the LacZ-NEO. (B) Southern
blot analysis of ClaI-digested genomic DNA from neomycin resistant and b -gal-positive ES clones.
A 5¢ external and a lacZ probe were used to distinguish homologous recombination events from
random integration. (C) Gel retardation analysis of GATA DNA-binding activity in protein extracts
from 1-week-old in vitro differentiated wild-type and mutant ES cells. The specificity of the
protein-DNA complex is demonstrated by competition with a 100-fold molar excess of unlabeled
oligo (C31T) or another GATA site (- 200) or an Sp1-binding site. The GATA complex is inhibited
by the addition of GATA4 antibody and results in a supershift. A GATA6 antibody also inhibited the
formation of the complex (not shown), however it inhibited the formation of all other shifts
including Sp1 and we concluded that this antibody is not specific for GATA6. A second antibody
showed no activity in the shifts at all. (D) PCR genotyping of 5.5 dpc embryos from GATA6+/-
intercrosses using three primers, P1, P2 and P3, to simultaneously amplify both wild-type (231 bp)
and targeted (375 bp) allele.
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a supershift. Thus GATA6-binding activity is absent or reduced
drastically in the mutant cells (Fig. 1C). Addition of anti-
GATA1 antibody did not affect any of these complexes and
anti-GATA6 antibodies inhibited any binding (data not shown).
Both the GATA6- /- and the GATA6+/- ES cells were injected
into blastocysts to obtain chimeric embryos and mice,
respectively. GATA6+/ - chimeras were bred to FVB and
C57/BL6 mice to obtain germline transfer of the GATA6-
negative allele. GATA6+/+ and GATA6+/- mice were
distinguished by Southern analysis as described above for the
ES cell lines, while PCR analysis with three primers (Fig.
1A,D, primers p1, p2 and p3) or in situ hybridization (Fig. 9)
was used to genotype embryos.
Expression of GATA6 prior to day 9.5 of
development
First, we analyzed the expression pattern of the lacZ marker in
heterozygote embryos. lacZ expression could be seen as early
as the blastocyst stage (3.5 dpc) in agreement with the
expression data of GATA6 in ES cells. This expression was
zygotic since it was observed in crosses between GATA6+/ -
males and wild-type females and also indicative of the
genotype since mutant blastocysts showed much higher levels
of lacZ expression than heterozygotes (Fig. 2B,A,
respectively). Staining was evident in only a proportion of the
cells of the inner cell mass, which corresponds with the
heterogeneous staining seen in ES cells in culture indicating
that staining is not uniform in equivalent cells. In addition, cells
lining the abembryonic region of the blastocoel cavity were b -
gal positive (Fig. 2A,B).
The expression of the lacZ reporter just prior to and during
heart formation was analyzed in heterozygous embryos from
7.0 to 9.5 dpc. Dissection of the embryos at 7.0 dpc showed
no b -gal staining in the embryo proper, but strong staining of
the parietal endoderm cells on the inside of the partially or
completely removed Reichert’s membrane (Fig. 2C,D). At 7.5
dpc, GATA6-driven lacZ expression was visible in the
mesoderm of a late primitive streak embryo (Fig. 3A) and
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Fig. 3. Embryonic expression of the mouse GATA6 gene, as demonstrated by b -galactosidase activity in mouse embryos heterozygous for the
lacZ insertion in the GATA6 locus. (A) An advanced primitive streak embryo at 7.5 dpc (ng, neural groove) shows mesodermal expression,
which is better visualized at 8.0 dpc as part of the lateral plate mesoderm (lpm) (B,D). This mesoderm contains the cardiogenic plate (cp),
which is b -gal positive as seen in a transverse section at the level of the head folds of an 8.0 dpc embryo in C. The expression persists as the
two heart primordia (hp) are formed (E) and during their fusion in the midline to form the linear heart tube (F). At 8.5 dpc after the looping of
the heart tube (ht), GATA6 is still expressed along the heart tube but staining predominates in the two horns of the sinus venosa (sv) and in the
developing foregut (G). Transverse section across the heart tube revealing that expression is restricted to only the myocardium (m) and
pericardium (p), and is not evident in the endocardium (e) (H).
Fig. 2. Expression of GATA6
gene, as detected by b -
galactosidase activity, in
early mouse embryos
heterozygous for the lacZ
insertion. (A,B) 3.5 dpc
embryos, blastocysts stage,
from heterozygote
intercrosses with clear
difference in the intensity of
the staining, presumably
corresponding to the presence of one (heterozygote mutant) or two (homozygote mutant) lacZ alleles respectively. Expression sites are both in
the inner cell mass and in cells lining the blastocoel cavity. (C) A 7.0 dpc embryo exposed from the decidua, just after gastrulation. The only
expression site is the parietal endoderm cells of the Reichert’s membrane, (d) decidua and (ec) egg cylinder. (D) A 5 m m transverse section of
the embryo in C in which the three germ layers, (e) ectoderm, (m) mesoderm and (ed) endoderm with the surrounding Reichert’s membrane
(Rm) and the stained parietal endoderm cells (pe) are indicated.
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subsequently staining was observed in the lateral plate
mesoderm, which contains the cardiogenic plate (Fig. 3B-D).
Expression persisted as the two heart primordia formed and
fused in the midline to form the heart tube (Fig. 3E,F). After
looping of the heart tube (8.5 dpc), GATA6-driven lacZ was
primarily expressed in the two horns of the sinus venosa and
in the foregut (Fig. 3G). A transverse section of the heart tube
shows that expression is restricted to the myocardium and
pericardium, but absent in the endocardium (Fig. 3H). At 9.5
dpc, expression was still observed in the heart tube, particular
in the inflow and outflow tracts (Fig. 4A,B). The myocardium,
but not the endocardium of the heart tube, was still positive
(Fig. 4C). The gene was also strongly expressed in the foregut
and hindgut and to a lesser extent in the midgut (Fig. 4A).
The absence of GATA6 leads to an early lethal defect
Intercrossing GATA6+/ - mice failed to produce any live born
GATA6- /- mice in 62 live offspring (mice derived from two
different ES cells clones were tested). Genotyping embryos
from as early as 6.5 dpc also showed no GATA6 - /- embryos
(Table 1). GATA6 null embryos could be found at 5.5 dpc (4
out of 20) and earlier (day 4.5 embryos and day 3.5
blastocysts). We therefore analyzed the expression of the
reporter gene during the phase of peri-implantation lethality.
At 4.5 dpc just prior to implantation, b -gal staining is restricted
to a population of cells on the blastocoelic surface of the inner
cell mass adjacent to the trophectoderm (Fig. 5A). However,
we have been unable to confirm that GATA6 is expressed at
4.5 dpc by whole-mount in situ hybridization. It is therefore
possible that the b -gal staining at this stage is a left over from
the expression at the blastocyst. After implantation, at 5.5 dpc,
b -gal staining was not detectable in heterozygous embryos
derived from heterozygous outcrosses. Expression could only
be detected at this stage in a subset of embryos obtained from
heterozygote intercrosses. In such crosses, a minority of the
embryos that were invariably much smaller than their
littermates showed a very specific b -gal staining in one or a
very few cells (Fig. 5B,C). These retarded embryos were
presumed to be GATA6 null embryos, although we were unable
to confirm their genotype by standard PCR after the embryos
had been fixed and analyzed for the presence of b -gal staining.
Sectioning of 5.5 dpc embryos revealed that a number of them
lacked part of the visceral endoderm and showed abnormal
development of the embryonic ectoderm that normally
underlies this part of the endoderm (Fig. 6).
Differentiation and lacZ expression were also investigated in
blastocysts flushed from heterozygous intercrosses at 3.5 dpc
and cultured under differentiating conditions (Suzuki et al.,
1997). After 5-9 days, the cultures were analyzed for cell type
and genotyped by PCR. In the early phases of culturing wild-
type, heterozygote and homozygote GATA6 null blastocysts,
all developed normally with attachment and outgrowth of the
trophoblast cells. However, in the GATA6 null blastocysts,
growth of the inner cell mass was severely impaired and, after
5 days, the ICM remained very small and its cells tended to
disperse (Fig. 7). After 9 days in culture, these cells detached
and disappeared (data not shown). Development of small,
Fig. 4. lacZ expression in a GATA6+/ - embryo at embryonic day 9.5.
(A) Whole-mount b -gal staining. Expression persists in the heart
tube, mainly in the inflow and outflow tracts, and very strong
expression can be seen in the foregut and hindgut as well as in the
midgut. (B) Higher magnification of the heart tube demonstrating
strong expression in the inflow and outflow tracts, but as shown in C,
the myocardium of the whole heart tube is still expressing GATA6.
Fig. 5. GATA6 expression during the phase of peri-implantation lethality. (A) A 4.5 dpc heterozygous embryo in which the b -gal staining is
restricted to a few cells on one side of the blastocoelic surface of the inner cell mass adjacent to the trophoectoderm. (B) An implanted 5.5 dpc
embryo from heterozygous intercrosses, which contains a few expressing cells and is much smaller than its littermates (C). (D) Heterozygous
blastocyst outgrowth, after 7 days in culture, in which expression is restricted to a few cells of the inner cell mass.
Table 1. Genotypes resulting from GATA6 heterozygous
mutant matings
+/- +/+ Total number
live born 37 (60) 25 (40) 62
9.5 dpc 24 (60) 16 (40) 40
8.5 dpc 64 (58) 47 (42) 111
7.5 dpc 6 (60) 4 (40) 10
6.5 dpc 86 (65) 47 (35) 133*
*Embryos were collected from 11 GATA6+/ - females and 1-3 empty
decidua were found per litter.
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migrating parietal endoderm cells was evident in all cultured
blastocysts. GATA6 expression was observed by b -gal staining
in a small subpopulation of inner cell mass cells in a 1-week-
old heterozygous blastocyst outgrowth (Fig. 5D).
These results suggest that the absence of GATA6 results in
lethality at 5.5 dpc, shortly after implantation, due to a defect
in cells derived from the inner cell mass. These may be
extraembryonic in nature and possibly the primary defect lies
in the primitive endoderm lineage.
In order to test this extraembryonic function of GATA6, we
made two types of chimeric embryos; the first, by injecting
wild-type blastocysts with GATA6 null ES cells to retain
wild-type genotype in extraembryonic tissues and, the
second, by the reciprocal combination to remove GATA6
function from extraembryonic tissues (Beddington and
Robertson, 1989).
GATA6 is required for extraembryonic development
Homozygote GATA6 null undifferentiated ES cells were
injected into C57/BL6 blastocysts and the developing
embryos were analyzed at 8.5 and 9.5 dpc. Staining for b -
galactosidase activity showed that the GATA6 - / - ES cells
could contribute effectively to the heart tube and sinus venosa
and that their progeny were present in both the myocardium
and pericardium (Fig. 8C-F). GATA6 - / - cells also contribute
to the gut. We therefore conclude that the absence of GATA6
does not lead to a cell autonomous defect in the epiblast that
is derivative of the inner cell mass giving rise to the embryo
proper. In addition, the GATA6 null cells clearly had not lost
their developmental potential to contribute to the heart and
gut. The latter was confirmed by the in vitro differentiation
of GATA6 null ES cells. They were differentiated in vitro (see
Materials and Methods) and analyzed after 23 days in
suspension cultures. The GATA6+/ - and GATA6 - / - embryoid
bodies showed no morphological differences (Fig. 8A,B) and
both contained contracting cells, indicating that
differentiation of cardiomyocytes was not inhibited in
GATA6 - / - tissues.
Because the extraembryonic tissues in the chimera
experiment were derived from the wild-type blastocyst, it
leaves the possibility that GATA6 is essential for the
development of the trophectoderm or the primitive endoderm,
and that it was defects in either or both of these tissues that
were responsible for the demise of the embryo. This would be
consistent with the abnormal endoderm observed in a number
of 5.5 dpc embryos (Fig. 6). In order to perform the reciprocal
chimera experiment, it was important to establish that GATA6
embryos were normally represented among blastocysts
selected for injection from heterozygote intercrosses.
Blastocysts were collected, selected for injection and then
genotyped. Homozygous null blastocysts constituted 20% of
the population.
After injecting intercross blastocysts with wild-type ES cells
and their implantation in pseudopregnant recipient mice, the
resulting embryos were analyzed at 7.5 dpc. The chimeric
embryos were dissected from Reichert’s membrane and the
cells in this membrane were genotyped. Since this tissue
receives a low, if any, contribution from the injected ES cells
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Fig. 6. Haematoxylin and eosin-stained
sagittal sections of 5.5 dpc embryos from
GATA6 heterozygous intercrosses.
(A,B) Normally developed embryos;
(C,D) embryos showing abnormal visceral
endoderm surrounding the embryonic
ectoderm (arrow).
Fig. 7. In vitro blastocyst outgrowths after 5 days in culture. (A,B) Wild-type and heterozygous blastocysts, respectively, with the expected
outgrowth of trophoblast cells and the formation of an inner cell mass surrounded by the visceral endoderm. (C,D) Homozygous mutants,
which exhibit normal outgrowth of the trophectoderm but have a small or dispersed inner cell mass. There is no evidence of a visceral
endoderm layer enveloping the ICM. In all three genotypes, parietal endoderm cells were observed at the periphery of the outgrowth.
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(Beddington and Robertson, 1989), its genotype would be
representative of the host blastocyst. Nuclei were prepared
from both the membrane and the embryo proper and subjected
to FISH genotyping using a probe specific for the mutant
GATA6 allele (the lacZ-neo gene, green) and a probe for a
control gene (the HIRA gene, red). 73 blastocysts were injected
and 58 implantation sites formed, from which 41 conceptuses
were recovered. Genotyping showed that 32 of the 41
Reichert’s membranes were heterozygote for lacZ-neo (two red
signals and one green, Fig. 9B), while the remaining 9
membranes were wild type (only two red dots, Fig. 9A). Thus
none of the embryos was derived from a GATA6 null
blastocyst, indicating that GATA6 is required for the
development of extraembryonic tissues.
DISCUSSION
Expression and role of GATA6 in the heart
In this paper, we describe the expression pattern and the role
of the transcription factor GATA6 using homologous
recombination to introduce the E. coli b -galactosidase (lacZ)
gene to inactivate GATA6 and to serve as a reporter for its
expression. Previous expression and in vitro binding studies
suggested a role of GATA6 in the development of the heart
(Laverriere et al., 1994; Morrisey et al., 1996; Evans, 1997;
Gove et al., 1997) and we therefore first analyzed the
expression pattern of the reporter gene during embryonic heart
formation in heterozygote embryos. As expected (Morrisey et
al., 1996), GATA6-driven lacZ expression is detected in the
lateral plate mesoderm (8.0 dpc) containing the cardiogenic
plate and persists during the differentiation and migration of
cardiomyocytes to form the heart tube. By day 8.5, when the
heart has looped, b -gal staining is still evident in both
myocardium and pericardium and strong expression is
observed in the developing gut.
Since homozygote mutants die well before heart formation,
the role of GATA6 in cardiogenesis could not be assessed
directly. Therefore GATA6 - / - ES cells were generated and their
developmental potential tested. The behavior of mutant cells in
embryoid bodies in vitro appeared indistinguishable from
heterozygous or the wild-type cells with respect to
differentiation of functional cardiomyocytes. In vivo when the
GATA6 - /- ES cells were injected into wild-type blastocysts, a
number of normal, highly chimeric embryos were obtained and
these showed a substantial contribution of the mutant cells to
both the heart and the gut. Thus, the absence of GATA6 protein
does not result in a cell autonomous defect in developing
cardiomyocytes. This supports the suggestion from the analysis
of GATA4 mutants (Narita et al., 1996; Kuo et al., 1997;
Molkentin et al., 1997) that there is a functional redundancy
between the two members of the family concerning cardiac
development. Unfortunately, elucidation of such a redundant
role is not possible through the study of heart development in
a double mutant background since GATA6 - /- lethality is much
earlier than the specification of cardiogenic mesoderm.
GATA6 null embryos and early expression
All GATA6 null embryos fail to develop to gastrulation and die
shortly after implantation at 5.5 dpc. Thus we investigated the
expression of GATA6 during peri-implantation development.
Fig. 8. Developmental potential of the GATA6 - /- ES cells. (A,B) b -
gal-stained embryoid bodies derived from ES cells differentiated in
vitro for 23 days in suspension culture. There is no morphological
difference between heterozygote and homozygote mutants and they
both display contraction activity. When GATA6 - / - ES cells were
injected into wild-type blastocysts their contribution to GATA6-
expressing tissues was assessed by b -galactosidase activity. (C) 8.5
dpc chimeric embryo demonstrating contribution to both heart tube
and sinus venosa and (D) transverse section of the heart tube
indicates that both myocardium and pericardium are colonized.
(E,F) 9.5 dpc chimeric embryos with contribution sites being all the
tissues that express GATA6 (Fig. 4A).
Fig. 9. FISH genotyping of Reichert’s membrane nuclei derived from
7.5 dpc chimeric embryos generated by injecting wild-type ES cells
into blastocysts from GATA6+/ - intercrosses. A cocktail probe was
used with a cosmid for the HIRA locus as a wild-type control (red)
and a plasmid with the lacZ-neo sequences to detect the GATA6
mutant allele. (A) A wild-type (two red dots) and (B) a heterozygous
(two red and one green dot) mutant embryo.
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Expression can first be seen in blastocysts (3.5 dpc) in a
subpopulation of cells in the inner cell mass and in some cells
lining the blastocoelic cavity. Interestingly, not all inner cell
mass cells stain and such nonuniform staining is also seen in
heterozygous lacZ-targeted ES clones, where blue staining is
evident as a ‘salt and pepper’ pattern in an otherwise apparently
homogeneous population of undifferentiated ES cells. Thus
GATA6(lacZ) may be cell cycle regulated, monoallelically
expressed or reveal some of the heterogeneity in pluripotent
cells. Before implantation at 4.5 dpc, when the primitive
endoderm has already differentiated as a distinct layer on the
surface of the inner cell mass (Nadijcka and Hillman, 1974;
Gardner, 1985), GATA6-driven lacZ is restricted to a localized
population of cells on the blastocoelic surface of the inner cell
mass adjacent to the trophectoderm. This very restricted
expression in a subset of ICM cells can also be seen in
heterozygote blastocyst outgrowths in vitro (Fig. 5D). We were
unable to confirm this restricted expression pattern at the RNA
level by in situ hybridization of GATA6 RNA. It is therefore
possible that GATA6 is not expressed at that stage. b -gal
activity may be very stable and remains detectable for a longer
time than GATA6 RNA. It would seem that it is this first phase
of GATA6 expression in the ICM of the blastocysts that is
critical for the survival of the embryo. However, it is not clear
whether GATA6 expression marks ICM cells that will become
the epiblast (giving rise to the embryo proper) or cells that will
differentiate into primitive endoderm, or a mixture of the two.
At gastrulation, a new site of expression is detected, reflected
by the very strong staining in the parietal endoderm cells on
the inner surface of the Reichert’s membrane. Although these
cells are derived from the primitive endoderm, it does not
appear that the expression at day 4.5 necessarily corresponds
to precursors of the parietal endoderm. At 5.5 dpc, no
expression in parietal endoderm could be detected and
therefore GATA6 is not continuously expressed in this lineage
from the blastocyst stage. The only expression that could be
detected at 5.5 dpc was seen in a few retarded embryos from
heterozygote intercrosses. Staining was seen in a few cells and
they appeared to be in extraembryonic sites. Since no staining
was ever seen in heterozygote outcrosses, these embryos are
presumed to be GATA6 homozygotes and thus indicate that
absence of GATA6 causes abnormalities immediately after
implantation, which are manifested as gross retardation and
abnormal primitive endoderm differentiation (Fig. 6).
Extraembryonic requirement for GATA6
The suggestion, based on expression pattern, that GATA6 is
required for the development of extraembryonic tissue is
supported by the generation of chimeric embryos. In a previous
study (Beddington and Robertson, 1989), it was shown that ES
cells when injected into blastocysts contribute mainly to the
epiblast. Occasionally a very low contribution could be
observed in trophectoderm and primitive endoderm. Injecting
GATA6 - /- ES cells into wild-type blastocysts generated a
number of normal highly chimeric embryos. This endorses the
notion that GATA6 is normally required in extraembryonic
linaeges. This conclusion is further supported by the opposite
experiment that demonstrated the inability of the wild-type ES
cells to rescue the GATA6- /- phenotype. Moreover, death of the
embryo (in vivo) or inner cell mass (in vitro) is not due to a
cell autonomous requirement for GATA6 in the epiblast but
rather to a defect in neighboring supportive tissues. Such a
crucial role for visceral endoderm in growth and patterning of
the embryo has been demonstrated in the analysis of other
knock-out phenotypes such as HNF4 (Chen et al., 1994), evx1
(Spryropoulos and Capecchi, 1994), nodal (Varlet et al., 1997)
and smad2 (Waldrip et al., 1998). Given the normality of the
trophectoderm outgrowth in GATA6 - /- blastocysts in vitro and
the presence of parietal endoderm cells, it is likely that the
primary defect lies in the visceral endoderm.
Function of GATA6
All GATA6 null embryos fail to develop to gastrulation and die
shortly after implantation at 5.5 dpc. Thus the first wave of
GATA6 expression in the ICM of the blastocyst is critical to
the survival of the embryo. The expression of the GATA factor
with overlapping expression in heart, GATA4, has not yet been
determined in vivo prior to gastrulation. However, about one
third of the embryos with an inactivated GATA4 gene fail to
gastrulate and this is thought to be due to defective formation
of visceral endoderm from primitive endoderm at day 4.5
(Molkentin et al., 1997). This is supported by the observation
that GATA4-deficient ES cells fail to form visceral endoderm
in culture (Soudais et al., 1995). Like GATA6 - /- cells, GATA4
null ES cells contribute extensively to normal chimeras when
injected into wild-type blastocysts (Narita et al., 1997). The
majority of GATA4 null embryos show a defect in the lateral-
to-ventral folding of the precardiac splanchic mesoderm and
its underlying endoderm at 7.5 dpc (Molkentin et al., 1997).
Both of these tissues also express GATA6. GATA6 expression
is increased in the GATA4-deficient tissues and this may be
responsible for the rescue of the majority of the embryos until
after gastrulation (Molkentin et al., 1997). Thus GATA6
appears to be the more critical factor at the earliest stages
where its absence cannot be compensated by GATA4. The
opposite appears to be the case in the tissues forming the heart
and gut. Although the level of GATA6 is raised, the absence of
GATA4 leads to a lethal defect in folding, while the basic
ability of the cells to differentiate appears to be maintained
(Molkentin et al., 1997). Interestingly, this lethal folding defect
in GATA4 - / - embryos is rescued in the presence of wild-type
visceral endoderm (Narita et al., 1997). Therefore, even here
the primary defect appears to be extraembryonic. We were of
course unable to determine the effect of a complete absence of
GATA6-expressing cells during early heart and gut formation
because of early lethality. However, GATA6 null ES cells were
able to contribute to all the early heart and gut cells in chimeric
embryos, which shows that the absence of GATA6 does not
lead to a cell autonomous defect in these tissues. The cells keep
their basic ability to differentiate as was observed in the
GATA4 null embryos. However the chimera experiments do
not show that the absence of GATA6 could have caused similar
cell movement problems as observed in the GATA4 null
embryos.
Overexpression of GATA4 in P19 cells leads to an increase
in beating cardiogenic myocytes, while its absence leads to
extensive apoptosis and cell death (Grepin et al., 1997).
Overexpression of GATA6 at the time that its expression
normally decreases in heart formation in Xenopus leads to an
excess of cells and thickening of the myocardial muscle (Gove
et al., 1997). Similar observations have been made for GATA1
in the haematopoietic system. The inactivation of GATA1 leads
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to an arrest of erythropoiesis in the foetal liver due to apoptosis
of differentiating red cells (Weiss and Orkin, 1995).
Overexpression of GATA1 leads to the opposite effect (Whyatt
et al., 1997; Whyatt and F. G., unpublished data).
GATA2 and GATA3 are, among other tissues, also expressed
in the haematopoietic system (Leonard et al., 1993). In the case
of GATA1 and GATA2, they have been shown to be
autoregulatory and crossregulatory (Weiss et al., 1994; Tsai et
al., 1991) and they can substitute for each other to a
considerable extent (Weiss et al., 1994). Nevertheless, they
each have a unique role in the development of the
haematopoietic system resulting in different phenotypes when
the genes have been inactivated in vivo (Pevny et al., 1991;
Tsai et al., 1994; Pandolfi et al., 1995; Ting et al., 1996). This
suggests that at least part of the function of GATA proteins is
not related to the unique properties present in each of the
particular GATA proteins, but rather on the conserved central
GATA DNA-binding motif (Tsai et al., 1998). In other words,
as long as sufficient amounts of any GATA protein are
produced at the appropriate time in particular cells they will be
functional.
Thus we suggest that GATA6 happens to be the first GATA
factor that is required for the growth of a population of cells
that contributes to the extraembryonic tissues in the developing
blastocyst. Absence of GATA6 would lead to the malfunction
of an extraembryonic tissue (probably visceral endodermal as
defined by position and chimeras), that is required for the
support and growth of the epiblast.
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